Literature DB >> 24973890

Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia.

Gabor Andocs1, Nora Meggyeshazi, Lajos Balogh, Sandor Spisak, Mate Elod Maros, Peter Balla, Gergo Kiszner, Ivett Teleki, Csaba Kovago, Tibor Krenacs.   

Abstract

In modulated electrohyperthermia (mEHT) the enrichment of electric field and the concomitant heat can selectively induce cell death in malignant tumors as a result of elevated glycolysis, lactate production (Warburg effect), and reduced electric impedance in cancer compared to normal tissues. Earlier, we showed in HT29 colorectal cancer xenografts that the mEHT-provoked programmed cell death was dominantly caspase independent and driven by apoptosis inducing factor activation. Using this model here, we studied the mEHT-related cell stress 0-, 1-, 4-, 8-, 14-, 24-, 48-, 72-, 120-, 168- and 216-h post-treatment by focusing on damage-associated molecular pattern (DAMP) signals. Significant cell death response upon mEHT treatment was accompanied by the early upregulation (4-h post-treatment) of heat shock protein (Hsp70 and Hsp90) mRNA levels. In situ, the treatment resulted in spatiotemporal occurrence of a DAMP protein signal sequence featured by the significant cytoplasmic to cell membrane translocation of calreticulin at 4 h, Hsp70 between 14 and 24 h and Hsp90 between 24- and 216-h post-treatment. The release of high-mobility group box1 protein (HMGB1) from tumor cell nuclei from 24-h post-treatment and its clearance from tumor cells by 48 h was also detected. Our results suggest that mEHT treatment can induce a DAMP-related signal sequence in colorectal cancer xenografts that may be relevant for promoting immunological cell death response, which need to be further tested in immune-competent animals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24973890      PMCID: PMC4255246          DOI: 10.1007/s12192-014-0523-6

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  43 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

3.  A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia.

Authors:  Giammaria Fiorentini; Petros Giovanis; Susanna Rossi; Patrizia Dentico; Raffaele Paola; Gina Turrisi; Paolo Bernardeschi
Journal:  In Vivo       Date:  2006 Nov-Dec       Impact factor: 2.155

Review 4.  Extracellular heat shock proteins in cell signaling and immunity.

Authors:  Stuart K Calderwood; Salamatu S Mambula; Phillip J Gray
Journal:  Ann N Y Acad Sci       Date:  2007-10       Impact factor: 5.691

5.  Impedance spectra of tumour tissue in comparison with normal tissue; a possible clinical application for electrical impedance tomography.

Authors:  B Blad; B Baldetorp
Journal:  Physiol Meas       Date:  1996-11       Impact factor: 2.833

Review 6.  [The role of radiotherapy in the induction of antitumor immune responses].

Authors:  G Multhoff; U S Gaipl; G Niedermann
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

7.  Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.

Authors:  Stephan R Scheffer; Heike Nave; Firouzeh Korangy; Karola Schlote; Reinhard Pabst; Elizabeth M Jaffee; Michael P Manns; Tim F Greten
Journal:  Int J Cancer       Date:  2003-01-10       Impact factor: 7.396

Review 8.  Tumor stress, cell death and the ensuing immune response.

Authors:  E Ullrich; M Bonmort; G Mignot; G Kroemer; L Zitvogel
Journal:  Cell Death Differ       Date:  2007-11-09       Impact factor: 15.828

Review 9.  The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.

Authors:  Mathias Gehrmann; Jürgen Radons; Michael Molls; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2008-02-05       Impact factor: 3.667

10.  Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis.

Authors:  Karin Pfister; Jürgen Radons; Raymonde Busch; James G Tidball; Michael Pfeifer; Lutz Freitag; Horst-Jürgen Feldmann; Valeria Milani; Rolf Issels; Gabriele Multhoff
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

View more
  26 in total

Review 1.  Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.

Authors:  Nicole S Klee; Cameron G McCarthy; Patricia Martinez-Quinones; R Clinton Webb
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-09-15

2.  Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial.

Authors:  Clifford L K Pang; Xinting Zhang; Zhen Wang; Junwen Ou; Yimin Lu; Pengfei Chen; Changlin Zhao; Xiaopu Wang; Hongyu Zhang; Sergey V Roussakow
Journal:  Mol Clin Oncol       Date:  2017-04-10

3.  Damage-Associated molecular pattern markers HMGB1 and cell-Free fetal telomere fragments in oxidative-Stressed amnion epithelial cell-Derived exosomes.

Authors:  Samantha Sheller-Miller; Rheanna Urrabaz-Garza; George Saade; Ramkumar Menon
Journal:  J Reprod Immunol       Date:  2017-08-24       Impact factor: 4.054

4.  Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity.

Authors:  Min Luo; Lei Shi; Fuhe Zhang; Feifan Zhou; Linglin Zhang; Bo Wang; Peiru Wang; Yunfeng Zhang; Haiyan Zhang; Degang Yang; Guolong Zhang; Wei R Chen; Xiuli Wang
Journal:  Int J Hyperthermia       Date:  2018-04-16       Impact factor: 3.914

5.  Extracellular vesicle mediated feto-maternal HMGB1 signaling induces preterm birth.

Authors:  Enkhtuya Radnaa; Lauren S Richardson; Samantha Sheller-Miller; Tuvshintugs Baljinnyam; Mariana de Castro Silva; Ananth Kumar Kammala; Rheanna Urrabaz-Garza; Talar Kechichian; Sungjin Kim; Arum Han; Ramkumar Menon
Journal:  Lab Chip       Date:  2021-05-18       Impact factor: 6.799

6.  Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.

Authors:  Yuk-Wah Tsang; Cheng-Chung Huang; Kai-Lin Yang; Mau-Shin Chi; Hsin-Chien Chiang; Yu-Shan Wang; Gabor Andocs; Andras Szasz; Wen-Tyng Li; Kwan-Hwa Chi
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

7.  Comparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cells.

Authors:  G Andocs; M U Rehman; Q-L Zhao; Y Tabuchi; M Kanamori; T Kondo
Journal:  Cell Death Discov       Date:  2016-06-13

8.  Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts.

Authors:  Tamas Vancsik; Csaba Kovago; Eva Kiss; Edina Papp; Gertrud Forika; Zoltan Benyo; Nora Meggyeshazi; Tibor Krenacs
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

9.  Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation.

Authors:  Sun Young Lee; Na Ri Lee; Dong-Hyu Cho; Jung Soo Kim
Journal:  Oncol Lett       Date:  2017-05-04       Impact factor: 2.967

10.  Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis.

Authors:  Sergey V Roussakow
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.